Year: 2020

…read more […]

President Donald Trump signed an executive order targeting social media companies. Yahoo Finance’s Alexis Keenan breaks down the details of the executive order on The Final Round. …read more […]

Las Vegas might not be reopening until June 4, but that didn’t stop us from beating the house this week with a bet on casinos.
That’s exactly what War Room members did in a classic “buy on the rumor, sell on the news” type of event.
And in the longer term, there is more money to be made.
With one look at the regional casinos in places like Mississippi, you can get a taste for the type of future action that the Vegas casinos could see.
People are dying to get out of the house, and wearing a mask isn’t hampering their hankering to …read more […]

Salesforce reported a mixed bag of earnings with results of $4.87B in revenue, which is up 30% year-over-year, while guidance for the coming quarter is lighter than anticipated. The Final Round breaks down the numbers. …read more […]

…read more […]

At two previous companies, new United Airlines CEO Scott Kirby developed a reputation for bluntness, often favoring honest answers over diplomatic ones. On Thursday, speaking at his first public forum since taking over last week from Oscar Munoz, Kirby showed he wouldn’t drop the act just because he now leads a Fortune 100 company. In […] …read more […]

(Bloomberg) — Salesforce.com Inc. trimmed its annual revenue and profit forecasts, indicating that the coronavirus-induced recession has weakened demand for the software maker’s cloud applications. Shares declined 4% in extended trading on the news.Sales in fiscal 2021 will be about $20 billion, down from an earlier projection of as much as $21.1 billion, the San Francisco-based company said Thursday in a statement. Analysts, on average, estimated $20.7 billion.The company expects profit, excluding some items, of $2.93 to $2.95 a share, compared with analysts’ projection of $3.14.Chief Executive Officer Marc Benioff, now heading the company solo after co-CEO Keith Block stepped …read more […]

(Bloomberg) — AstraZeneca Plc’s blockbuster drug Tagrisso cut the risk of lung cancer death or relapse by four-fifths over three years, according to detailed results from a study that raises survival prospects for patients in the early stages of the deadly disease.Adding Tagrisso to the regimen of early-stage lung cancer patients who had undergone surgery reduced the risk of dying or disease recurrence by 79%, compared with a placebo, according to the research. Patients’ tumors also had a mutation in a cancer-linked gene, called EGFR. AstraZeneca will present the results at the American Society of Clinical Oncology’s annual conference on …read more […]